The primary outcome of interest was time to first hospitalized AKI, defined by a ≥50% increase from nadir to peak inpatient SCr measurement. This definition is adapted from the Kidney Disease Improving Global Outcomes (KDIGO) AKI guidelines,26 and is more stringent to reduce false positives and improve specificity.27 We used inpatient SCr measurements only to define hospitalized AKI to reduce the risk of misclassifying progression of CKD as AKI. We staged AKI according to KDIGO guidelines26 and included: Stage 1; peak inpatient SCr 1.5–1.9 times nadir Scr; stage 2; peak inpatient SCr 2.0–2.9 times nadir Scr, and stage 3; peak inpatient SCr ≥3.0 times nadir Scr. AKI Hospitalizations were ascertained through participant self-report and hospital queries and confirmed via medical records review.28,29 SCr values measured during these hospitalizations were systematically abstracted and organized to determine AKI status. Follow-up was through December 31, 2017.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.